Author

Madeleine E. Urbanek

Creighton UniversityPrimary ORCID profile (0000-0002-0320-2260 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Madeleine E. UrbanekiD1 paper · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

Jian ZuoiD· 1 shared Kimberlee P. GiffeniD· 1 shared Marisa ZallocchiiD· 1 shared Pezhman SalehiiD· 1 shared Santanu Hati· 1 shared Sarath VijayakumariD· 1 shared Yuju Li· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Jian ZuoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencebioRxivPreprintJan 26, 2022

In silico transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss

Pezhman Salehi, Marisa Zallocchi, Sarath Vijayakumar…·Jian Zuo

The paper uses in silico transcriptomics to identify FDA-approved drugs and pathways that protect against cisplatin-induced hearing loss, validating niclosamide as a potential otoprotectant.

2 citations

𝕏 PostBluesky